View Item 

Show simple item record

FDA and AAPS Report of the Workshop on Principles and Practices of In Vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalence

dc.contributor.authorSkelly, Jerome P.en_US
dc.contributor.authorYacobi, Avrahamen_US
dc.contributor.authorShah, Vinod P.en_US
dc.contributor.authorFlynn, Gordon L.en_US
dc.contributor.authorMaibach, Howard I.en_US
dc.contributor.authorWester, Ronald C.en_US
dc.contributor.authorGuy, Richard H.en_US
dc.date.accessioned2006-09-08T19:20:25Z
dc.date.available2006-09-08T19:20:25Z
dc.date.issued1987-06en_US
dc.identifier.citationSkelly, Jerome P.; Shah, Vinod P.; Maibach, Howard I.; Guy, Richard H.; Wester, Ronald C.; Flynn, Gordon; Yacobi, Avraham; (1987). "FDA and AAPS Report of the Workshop on Principles and Practices of In Vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalence." Pharmaceutical Research 4(3): 265-267. <http://hdl.handle.net/2027.42/41513>en_US
dc.identifier.issn0724-8741en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41513
dc.format.extent490953 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherPharmacyen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.titleFDA and AAPS Report of the Workshop on Principles and Practices of In Vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalenceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor, Michigan, 48103en_US
dc.contributor.affiliationotherAAPS, Alexandria, Virginia, 22314en_US
dc.contributor.affiliationotherDivision of Biopharmaceutics, FDA, Rockville, Maryland, 20857en_US
dc.contributor.affiliationotherSchool of Pharmacy, University of California, San Francisco, California, 94143en_US
dc.contributor.affiliationotherDepartment of Dermatology, University of California, San Francisco, California, 94143en_US
dc.contributor.affiliationotherSchool of Pharmacy, University of California, San Francisco, California, 94143en_US
dc.contributor.affiliationotherDivision of Biopharmaceutics, FDA, Rockville, Maryland, 20857en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41513/1/11095_2004_Article_306362.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1016428716506en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_306362.pdf
Size:
479.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.